Primary regulatory
Retatrutide in participants with obesity and cardiovascular disease
Phase 3 study NCT05882045 in participants with severe obesity and established cardiovascular disease. This is one study in the TRIUMPH program, not the TRIUMPH-1 pivotal obesity trial.
ClinicalTrials.gov / U.S. National Library of MedicinePublished 2023-06-02Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- ClinicalTrials.gov / U.S. National Library of Medicine
- Source type
- Primary regulatory
- Registry ID
clinicaltrials-gov-retatrutide-triumph- Trial ID
- NCT05882045
Source usage
Linked from 2 pages
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.